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The calcium-activated phosphodiesteratic hydrolysis of 32p-labeled phosphati- 
dylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in prelabeled 
nerve ending membranes is inhibited by the aminoglycosides neomycin and gen- 
tamicin, and to a lesser extent, by streptomycin. The inhibition is overcome by 
increasing concentrations of Ca 2 +, indicating that the aminoglycosides exert their 
effect by displacing Ca 2+ from lipid. 
INTRODUCTION 
It has been known for some time that the aminoglycoside antibiotics bind 
tightly to polyphosphoinositides (1-3), and it has been proposed that their 
nephrotoxicity and ototoxicity may be related to their effects on the me- 
tabolism of these acidic lipids (4). It has previously been shown that these 
agents block phosphatidylinositol phosphate (PIP) kinase (5-7) and phos- 
phatidylinositol 4,5-bisphosphate (PIP2) and PIP monoesterase (5, 6, 8). 
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Downes and Michell (9) demonstrated endogenous phosphodiesteratic ac- 
tivity in ery throcytes  ghosts that cleaves PIP2 and PIP in the presence of 
Ca 2§ , and that the degradation could be blocked by aminoglycosides. 
Membranes  derived from nerve endings, which in contrast to erythro- 
cytes,  support  ligand-activated stimulation of lipid labeling also have 
phosphodiesterat ic activity against the polyphosphoinositides (10). Since 
there has been much recent  interest in the receptor-mediated phospho- 
diesteratic cleavage of the polyphosphoinosit ides,  particularly of PIP2, to 
form diacylglycerol and inositol 1,4,5-trisphosphate (IP3), we have ex- 
amined the effects of aminoglycoside antibiotics on the activation by Ca 2 + 
of the degradation of  the polyphosphoinosit ides in prelabeled nerve ending 
membranes.  
E X P E R I M E N T A L  PROCEDURE 
Membranes were prepared by sequential freezing, thawing and subsequent washing of 
nerve endings that had been prelabeled with 3zpi (10). Following further preincubation for 
15 rain in bulk, aliquots of the labeled membranes (0.1-0.2 mg of protein) were incubated 
under various conditions for 5 min at 37~ with shaking, in a final volume of 0.25 ml of a 
buffer containing 30 mM HEPES/NaOH (pH 7.4) and 0.25 mM EGTA. The incubations 
were terminated by the addition of 1.5 ml of chloroform-methanol (1:2 by vol). Following 
extraction, lipids were separated by TLC, located autoradiographically, scraped and counted 
by liquid scintillation technique (10). Water-soluble compounds were separated on high 
voltage paper electrophoresis (pH 1.5). Bands, located by autoradiography, were cut out 
and counted (10, 11). Protein was determined spectrophotometrically (12). 
R E S U L T S  AND DISCUSSION 
Addition of 1 mM neomycin or gentamicin to incubations of 32p-pre- 
labeled nerve ending membranes resulted in inhibition of the Ca 2 +-acti- 
vated diesteratic degradation of both PIP2 and PIP (Table I). Streptomycin 
appeared much less potent  in inhibiting the breakdown. The relative de- 
gree of  inhibition corresponds with the known ability of the various ami- 
noglycosides to displace Ca 2+ from synaptic membranes (13). Neomycin  
caused a 50% inhibition of  PIP2 and PIP breakdown at about 0.15 mM 
and 0.35 mM, respectively.  This is consistent with the higher affinity of 
neomycin for PIP2 than for PIP (1). Gentamicin also inhibited PIP2 break- 
down more effectively than that of PIP. In experiments on ery throcyte  
membranes in which only the release of IP3 and inositol 1,4-bisphosphate 
(IP2) were measured,  Downes and Michell (9) obtained 50% inhibition at 
1 and 7 mM neomycin,  respectively.  It should be noted in addition that 
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TABLE I 
THE EFFECT OF AMINOGLYCOSIDES ON THE DIESTERATIC DEGRADATION OF 
POLYPHOSPHOINOSITIDES 
Inhibition (%) 
Aminoglycoside PIP2 PIP 
Neomycin 80.5 _+ 6.7 57.8 _+ 2.7 
Gentamicin 74.1 _+ 3.2 46.5 _+ 3.4 
Streptomycin 28.1 _+ 1.6 24.9 _+ 0.7 
Nerve ending membranes were incubated as described in the text, in the presence or absence 
of 0.4 mM free Ca z+ and 1 mM aminoglycoside as indicated. Since no significant effect of 
the aminoglycosides on radiotracer recovered as polyphospboinositides was observed in the 
absence of Ca z+ , these values were pooled. The values are expressed as percent inhibition 
of  the Ca2+-induced loss of  radiotracer, which was from 8716 _+ 137 cpm (SEM, n = 12) 
in the absence of Ca 2+ to 4648 _-2- 116 cpm (SEM, n = 3) in the presence of Ca 2+ for PIP2, 
and from 10076 _+ 1 5 7 c p m ( S E M ,  n = 12) to 5753 _+ 177cpm(SEM,  n = 3) for PIP. 
these authors employed a higher membrane concentration (2-2.5 mg/ml 
of protein) than used in the present study. 
Ca 2+ was required for the phosphodiesteratic degradation of the po- 
lyphosphoinositides, with an optimum in the region of 0.4-1.0 x 10 -3 M 
(Figure I). Higher concentrations of Ca 2+ did not enhance further deg- 
radation of PIP and slightly inhibited PIP2 breakdown. While concomitant 
release of the inositol phosphates could be observed, there also appeared 
to be breakdown of IP3 to IP2. This breakdown is known to be catalyzed 
by Mg 2+ (14), and while it was not added, tightly bound Mg 2+ may have 
nevertheless been present in the preparation. However, it should be noted 
that MgZ+-catalyzed monoesteratic degradation of PIP2 and PIP is not 
found under these conditions (10). ATP, and its non-hydrolyzable analog, 
APPCP, at 1 mM concentrations, appeared to block IP3 breakdown, pos- 
sibly by chelation of the residual Mg 2+. The nucleotides were not em- 
ployed in the present study, since they precipitated neomycin. Neomycin 
itself appeared to inhibit degradation of IP3 at higher Ca 2 + levels. It can 
also be seen from Figure 1 that inhibition of the phosphodiesteratic ac- 
tivity by neomycin was most apparent at low [Ca 2+ ] and that the effect 
of the aminoglycoside on lipid degradation could be abolished by increas- 
ing the concentration of the cation. 
Studies of PIP kinase (5-7) and polyphosphoinositide monoesterases 
(5, 6, 8) as well as of phosphodiesteratic cleavage support the thesis that 
the aminoglycosides exert their effects by binding to the substrate rather 
than to the various enzymes. Although phosphatidylinositol binds ami- 
1022 VAN ROOIJEN AND AGRANOFF 
7 - PiP2 
,_ - ~ 
r r  
LU 9 > 
0 
o 
~ 7  







8 0 4 
mM Ca ++  
0 0 8 0 
FIG. 1. The effect of neomycin on the phosphodiesteratic degradation of the polyphos- 
phoinositides PIP2 and PIP to IP3 and IP2, respectively, activated by various concentrations 
of Ca 2 +. Nerve ending membranes were incubated as described in the text, in the presence 
( I )  or absence ((3) of 1 mM neomycin and various calculated concentrations (in EGTA 
buffer) of free Ca 2 +, as indicated. The incubations were terminated and the lipids and water- 
soluble compounds analyzed as described in the text. Each value represents the mean of 
duplicate determinations, from an experiment representative of 2-5 experiments. 
noglycosides less tightly, similar observations have been made on the 
effects of aminoglycosides on the phosphodiesteratic breakdown of this 
lipid (15, 16). The present results are compatible with both the known 
binding of divalent cations to the polyphosphoinositides (17) and the re- 
quirement of Ca 2 + for phosphodiesteratic cleavage. The aminoglycoside/ 
Ca 2+ ratio may then affect availability of the substrate for the phospho- 
diesterase, and might account for the lack of an effect by neomycin on 
CaZ+-activated erythrocyte polyphosphoinositide phosphodiesterase by 
Marche et al. (7), in which a neomycin/Ca 2+ ratio of 0.3 was used in 
contrast to the results of Downes and Michell (9) who employed ratios 
of 2 and higher. 
In the tissues in which ligand-stimulated degradation of polyphosphoi- 
nositides has been documented, there is preferential degradation of PIP2 
(18). Attempts with membrane preparations to demonstrate a differential 
susceptibility of the two polyphosphoinositides to CaZ+-activated phos- 
phodiesteratic degradation do not yet permit discrimination of PIP2 from 
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PIP breakdown (10). The availability of bound inositides to C a  2+ and 
aminoglycosides appear to be rather similar. While the present results 
suggest that PIP2 in nerve ending membranes may bind Ca e+ somewhat 
better than PIP, the consequent effect on the diesteratic degradation does 
not appear to be sufficient to account for the observed difference in se- 
lectivity seen in ligand-stimulated degradation of PIP2 in intact cells and 
C a  2 + - a c t i v a t e d  cleavage in membrane preparations. 
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